- Report
- July 2023
- 328 Pages
Europe
From €2418EUR$2,750USD£2,088GBP
- Report
- April 2024
- 137 Pages
Global
From €2637EUR$2,999USD£2,277GBP
- Report
- May 2024
- 170 Pages
Global
From €5232EUR$5,950USD£4,518GBP
- Report
- September 2023
- 93 Pages
Global
From €5232EUR$5,950USD£4,518GBP
- Report
- February 2023
- 150 Pages
Global
From €5232EUR$5,950USD£4,518GBP
- Report
- October 2024
- 87 Pages
Spain
From €2616EUR$2,975USD£2,259GBP
€3077EUR$3,500USD£2,658GBP
- Report
- May 2024
- 85 Pages
Vietnam
From €2616EUR$2,975USD£2,259GBP
€3077EUR$3,500USD£2,658GBP
- Report
- May 2024
- 185 Pages
Global
From €3363EUR$3,825USD£2,904GBP
€3957EUR$4,500USD£3,417GBP
- Report
- May 2024
- 186 Pages
Global
From €3363EUR$3,825USD£2,904GBP
€3957EUR$4,500USD£3,417GBP
- Report
- April 2024
- 180 Pages
Global
From €3363EUR$3,825USD£2,904GBP
€3957EUR$4,500USD£3,417GBP
- Report
- April 2024
- 130 Pages
North America
From €2990EUR$3,400USD£2,582GBP
€3517EUR$4,000USD£3,037GBP
- Report
- April 2024
- 180 Pages
Global
From €3363EUR$3,825USD£2,904GBP
€3957EUR$4,500USD£3,417GBP
- Report
- April 2024
- 180 Pages
Global
From €3363EUR$3,825USD£2,904GBP
€3957EUR$4,500USD£3,417GBP
- Report
- November 2023
- 70 Pages
United States
From €2616EUR$2,975USD£2,259GBP
€3077EUR$3,500USD£2,658GBP
- Report
- October 2023
- 77 Pages
United States
From €2616EUR$2,975USD£2,259GBP
€3077EUR$3,500USD£2,658GBP
- Report
- July 2023
- 87 Pages
Europe
From €2990EUR$3,400USD£2,582GBP
€3517EUR$4,000USD£3,037GBP
- Report
- August 2024
- 85 Pages
India
From €2616EUR$2,975USD£2,259GBP
€3077EUR$3,500USD£2,658GBP
- Report
- November 2023
- 90 Pages
France
From €2616EUR$2,975USD£2,259GBP
€3077EUR$3,500USD£2,658GBP
- Report
- April 2023
- 114 Pages
Global
From €4177EUR$4,750USD£3,607GBP
- Report
- April 2023
- 135 Pages
Global
From €4177EUR$4,750USD£3,607GBP

The biocompatibility market is a subset of the biotechnology industry that focuses on the safety and compatibility of materials used in medical devices and implants. It involves the testing of materials to ensure they are non-toxic, non-allergenic, and non-carcinogenic. The market also includes the development of materials that are biodegradable and biocompatible, as well as the development of methods to assess the safety of materials.
The biocompatibility market is driven by the increasing demand for medical devices and implants, as well as the need for safer and more effective materials. The market is also driven by the increasing demand for personalized medicine, as well as the need for materials that are compatible with the human body.
Some companies in the biocompatibility market include Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Merck KGaA, Thermo Fisher Scientific, Inc., and Sigma-Aldrich Corporation. Show Less Read more